1
Neven, P., Paridaens, R., Pelgrims, G., Martens, M., Bols, A., Goeminne, JC., Vindevoghel, A., Demol, J., Stragier, B., De Greve, J., Fontaine, C., Van Den Weyngaert, D., Becquart, D., Borms, M., Cocquyt, V., Van Den Broecke, R., Selleslags, J., Awada, A., Dirix, L., Van Dam, P., Azerad, Marie-Agnès, Vandenhoven, G., Christiaens, MR.
2008
2008
2
Meegdes, M., Geurts, S.M.E., Erdkamp, F.L.G., Dercksen, M.W., Vriens, B.E.P.J., Aaldering, K.N.A., Pepels, M.J.A.E., Winkel, L.M.H., Teeuwen, N.J.A., Boer, M., Tjan-Heijnen, V.C.G.
Veröffentlicht in: Meegdes , M , Geurts , S M E , Erdkamp , F L G , Dercksen , M W , Vriens , B E P J , Aaldering , K N A , Pepels , M J A E , Winkel , L M H , Teeuwen , N J A , Boer , M & Tjan-Heijnen , V C G 2022 , ' The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2-advanced breast cancer patients: A study of the Dutch SONABRE Registry ' , International Journal of Cancer , vol. 150 , no. 1 , pp. 124-131 . https://doi.org/10.1002/ijc.33785;
2022
Veröffentlicht in: Meegdes , M , Geurts , S M E , Erdkamp , F L G , Dercksen , M W , Vriens , B E P J , Aaldering , K N A , Pepels , M J A E , Winkel , L M H , Teeuwen , N J A , Boer , M & Tjan-Heijnen , V C G 2022 , ' The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2-advanced breast cancer patients: A study of the Dutch SONABRE Registry ' , International Journal of Cancer , vol. 150 , no. 1 , pp. 124-131 . https://doi.org/10.1002/ijc.33785;
2022